# Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

> **NCT00362297** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 31 (actual)

## Conditions studied

- Genital Herpes

## Interventions

- **DRUG:** acyclovir
- **DRUG:** valacyclovir

## Key facts

- **NCT ID:** NCT00362297
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-12
- **Final completion:** 2011-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362297, "Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00362297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*